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Laurus nobilis (laurel) aqueous leaf extract’s
toxicological and anti-tumor activities in
HPV16-transgenic mice
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Cancers induced by human papillomavirus (HPV) infection remain a significant public health threat,
fueling the study of new therapies. Laurel (Laurus nobilis) compounds and extracts recently showed
in vitro activity against HPV-transformed cell lines. This work aims to evaluate the in vivo efficacy and
hepatic toxicity of a laurel extract in a transgenic mouse model of HPV16-induced cancer. The extract was
administered in drinking water (20 mg per animal per day) for three consecutive weeks, using four experi-
mental groups (n = 10) (group I: HPV16−/− without treatment, group II: treated HPV16−/−, group III: HPV16+/−
without treatment and group IV: treated HPV16+/−). Following the treatment period, animals were sacrificed
and skin samples were used to classify skin lesions histologically. Toxicological parameters included hemato-
logical and biochemical blood markers, splenic and hepatic histology and hepatic oxidative stress. The
extract did not prevent the progression of HPV16-induced cutaneous lesions in this model. The treated wild-
type animals showed mild hepatitis, while transgenic animals suffered weight loss. However, there were no
changes concerning hematological, biochemical and hepatic oxidative stress markers.
1. Introduction
Laurus nobilis L., popularly known as laurel, is native to the
Mediterranean region. Its dried leaves and the essential oil
originating from leaves are used as spices and flavoring com-
pounds in the culinary and food industries.1 Laurel has great
importance due to its diverse medicinal applications. It has
been traditionally used to treat gastric problems, such as
changes in digestion, eructation and flatulence.2 According to
Iranian traditional medicine, the leaf essential oil of laurel has
been used as an antiepileptic remedy.3 These anticonvulsive
properties were also evaluated against experimental seizures
induced in a mice model.4 Laurel is also rich in active sub-
stances with antibacterial, antifungal and antitumor pro-
perties.5,6 In general, most antineoplastic drugs are associated
with mild to severe side effects and their use is not always
effective. So, there is a worldwide endeavor to discover new
antineoplastic drugs from plants used in traditional medicine,
which are more effective and more affordable and have fewer
side effects.7 Many substances isolated from plants, or plant
extracts, show anti-neoplastic activity. These are often anti-
oxidant and anti-inflammatory substances like curcumin and
quercetin.8 Ginger (Zingiber officinale),9 cinnamon
(Cinnamomum spp.),10 and laurel (Laurus nobilis) extracts also
contain substances with anti-oxidant and anti-inflammatory
properties.5,6 Recently, aqueous and methanolic laurel extracts
obtained from wild and cultivated plants showed significant
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in vitro activity against cervical cancer (HeLa) cells transformed
by HPV18.11 Given these results, an in vivo efficacy study is
now desirable, in order to advance the pre-clinical study of
these extracts. Accordingly, the present work aims to study the
in vivo effects of a laurel aqueous extract, in a transgenic
mouse model of cancer induced by the high-risk HPV type 16
(HPV16). Considering that the previous in vitro study also
showed some hepatocellular toxicity, multiple in vivo toxico-
logical parameters were also studied. The mouse model
chosen for this purpose is transgenic for the complete HPV16
early region and develops pre-malignant and malignant
lesions at multiple sites.12 This model was previously used
by our team to test other natural compounds, including
vegetable toxins like ptaquiloside from bracken (Pteridium
spp.)13 and dietary polyphenols like curcumin and rutin.8 In
these previous studies, these transgenic animals showed a
strong predisposition to develop severe hepatic and splenic
inflammation, making them a suitable model to test both
the efficacy and the potential hepatotoxicity of laurel
extracts.
2. Materials and methods
2.1 Sample preparation
A wild sample of Laurus nobilis L. (laurel fresh leaves) was col-
lected in the autumn of 2012 in Bragança, Portugal.
Morphological key characters from the Flora Iberica were used
for plant identification. Voucher specimens are deposited in
the herbarium of the Escola Superior Agrária de Bragança
(BRESA). The sample was lyophilized (FreeZone 4.5, Labconco,
Kansas, USA) in order to preserve as much as possible its
chemical composition until analysis. Afterwards, the sample
was reduced to a fine dried powder (20 mesh) and mixed to
obtain a homogenate sample and preserved in a container con-
taining silica gel at −20 °C, until further analysis.
The aqueous extract (infusion) was obtained by adding
1 L of boiling distilled water to 10 g of the powdered plant
material. Afterwards, the mixture was left to stand at room
temperature for 5 min, filtered under reduced pressure,
frozen, and then lyophilized to obtain a powder dry
extract.14
The extract was further dissolved in water at a concentration
of 20 mg mL−1, based on the phenolic compound concen-
tration in this solution (336 µg mL−1) and on the GI50 value
obtained in the in vitro studies performed with HeLa cells
(88 µg mL−1).11 Taking into account these values, it was
decided to give 4× the concentration of the GI50 value to guar-
antee the phenolic compound concentration. The solution was
renewed every 3 consecutive days for the in vivo studies.
2.1.1. Phenolic compounds profile and stability of the
aqueous extracts. The phenolic compounds were determined
in a Dionex Ultimate 3000 UPLC (Thermo Scientific, San Jose,
C A, USA), equipped with a diode-array detector (DAD, 280, 330
and 370 nm as preferred wavelengths), and a mass detector
equipped with an ESI source (Linear Ion Trap LTQ XL, Thermo
Finnigan, San Jose, CA, USA). The identification of the
different phenolic compounds was performed by comparison
with available commercial standards, or tentatively identified
using reported data from the literature. For quantitative ana-
lysis, a calibration curve for each available phenolic standard
was constructed based on the UV signal or when no commer-
cial standard was available, a similar compound from the
same phenolic group was used as a standard15 and the results
were expressed in µg per mL of infusion.
The stability of the drinking water was evaluated for 5 con-
secutive days, at room temperature. In this study, the aqueous
extract was prepared at the feeding concentration and analyzed
daily through an LC-DAD-ESI/MS system, to visualize if there
was degradation of any compounds.
2.2. Mice
For the accomplishment of this experimental work, forty
female Mus musculus of the FVB/n strain were used: twenty
transgenic (hemizygotic HPV16+/−) and twenty wild-type
(homozygous HPV16−/−) mice aged 20–22 week-old. At this
age, cutaneous lesions on this mouse strain start progressing
from the hyperplastic to the dysplastic stage, providing an
opportunity to experimentally block this progression. Female
mice were selected in order to minimize aggressive behavior
between animals, frequently observed in male animals. The
mouse strain was generously donated by Drs Jeffrey Arbeit and
Douglas Hanahan from the University of California, through
the National Cancer Institute Mouse Repository (USA). The
animals were genotyped using a polymerase chain reaction
technique, as previously described.16,17
2.3. Experimental procedures
The animals were kept according to the national legislation
(Decree-Law 113/2013, August 7) and European Directive 2010/
63/EU on the protection of animals for experimentation, after
approval by UTAD’s Ethics Committee (10/2013) and the
Direção Geral de Alimentação e Veterinária (authorization
number 0421/000/000/2014). The animals were kept under con-
trolled experimental conditions of temperature (23 ± 2 °C),
light–dark cycle (light between 8.00–20.00 h) and relative
humidity (50 ± 10%). Throughout the experiment, mice were
fed a standard diet (4RF21 GLP, Mucedola, Italy) ad libitum
and they drank tap water. Animals were divided into four
groups: groups I (HPV16−/−, n = 10), II (HPV16−/−, n = 10), III
(HPV16+/−, n = 10), and IV (HPV16+/−, n = 10). Animals from
groups II and IV were administered laurel extract in drinking
water at a dose of 20 mg per animal per day, for three consecu-
tive weeks. The animal’s weights and their food and water con-
sumption were recorded every five days; at the same time,
animals were carefully observed to confirm their well-being. At
the end of the third week, all animals were sacrificed by intra-
peritoneal administration of a mixture of xylazine and keta-
mine, followed by cardiac puncture exsanguination, according
to the FELASA guidelines.18
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2.3.1. Determination of microhematocrit. Blood samples
were centrifuged in capillary tubes, using a centrifuge with an
adapter for microhematocrit tubes, at 9000 rpm for 5 minutes.
2.3.2. Serum biochemistry. The blood samples were
allowed to clot and centrifuged at 3000 rpm for 15 minutes
(4° C). The serum was separated and frozen at −80 °C until
use. The serum concentrations of creatinine, urea, aspartate
aminotransferase (AST), alanine aminotransferase (ALT) and
gamma glutamyl transferase (GGT) were determined in an
autoanalyzer (Prestige 24i, Cormay PZ).
2.3.3. HPV16-induced lesions. Chest skin samples were
fixed in 10% neutral buffered formalin and paraffin-
embedded. Histological slides were stained with hematoxylin
and eosin (H&E) for observation under optical microscopy and
histological classification, as normal skin, epidermal hyperpla-
sia and epidermal dysplasia, as previously described.8 Briefly,
epidermal hyperplasia was characterized by an increased
number of epidermal layers, with an increased epidermal
thickness and normal differentiation. Epidermal dysplasia was
diagnosed based on aberrant differentiation, with suprabasal
mitotic activity, nuclear pleomorphism, nuclear crowding,
aberrant keratinization, disorganization of epidermal layers
and sub-epidermal inflammation and neovascularization.
2.3.4. Hepatic and splenic histology. The liver and spleen
were selected for histological observation, because these
organs have been previously described to suffer from severe
inflammation in this animal model,8 and are thus particularly
susceptible to additional toxic damage. Liver samples were
classified as a normal liver or as hepatitis of 3 degrees of
increasing severity (grades I, II and III). Grade I hepatitis was
characterized by Kupfer cell hyperplasia with the possible pres-
ence of multifocal microabscesses. Grade II hepatitis showed
moderate to intense, multifocal, mixed periportal leukocytic
infiltration. Grade III hepatitis was diagnosed when periportal
infiltrates became coalescing, forming bridges between adja-
cent portal spaces. Splenic samples were classified as a normal
spleen, splenic white pulp hyperplasia and granulomatous
splenitis. White pulp hyperplasia was characterized by a predo-
minance of white pulp lymphoid tissue over the red pulp, with
the formation of prominent germinal centers. The diagnosis
of granulomatous splenitis was reserved for lesions showing
extensive destruction of the splenic architecture by a diffuse
granulomatous reaction with a predominance of macrophages
and fibroblasts.
2.3.5. Hepatic oxidative stress. For determining oxidative
stress parameters, livers were homogenized in cold buffer solu-
tion (0.32 mM of sucrose, 20 mM of HEPES, 1 mM of MgCl2,
and 0.5 mM of phenylmethyl sulfonylfluoride PMSF, prepared
in ethanol to prevent protein degradation, pH 7.4), using a
motor-driven Teflon and glass Potter-Elvehjem homogenizer.
The homogenate was centrifuged at 15 000g for 20 minutes at
4 °C (Sigma model 3K30, Osterode, Germany) and super-
natants were collected for analysis. The reactive oxygen species
(ROS) synthesis was estimated by using a fluorescent 2,7-
dichlorofluorescein diacetate (DCFDA) probe, following the
method previously published19 with excitation and emission at
485 and 530 nm, respectively. DCF was used for constructing a
standard curve (0–100 nM). The activity of superoxide dismu-
tase (Cu/Zn-SOD) was determined by the nitroblue tetrazolium
(NBT) reduction generated by the xanthine/xanthine oxidase
system at 560 nm.20 SOD from bovine erythrocytes was used
for constructing a standard curve (0–3.75 U mL−1). The activity
of catalase (CAT) was determined at 240 nm in accordance
with a previously published method21 and was calculated
using bovine catalase as a standard (0–5 U mL−1). Glutathione
peroxidase (GPx) activity was determined at 340 nm (ref. 22)
using the extinction coefficient of 6.22 mM−1 cm−1.
Glutathione reductase (GR) activity was determined by measur-
ing the increase in the absorbance of NADPH at 340 nm (ref.
23) using a molar extinction coefficient of 6.22 mM−1 cm−1.
Gluthathione S-transferase (GST) activity was determined by
the increase in absorbance at 340 nm due to the conjugation
of the thiol group of glutathione to the 1-chloro-2,4-dinitroben-
zene (CDNB) substrate,24 using the molar extinction coefficient
of 9.60 mM−1 cm−1. The glutathione levels were determined by
measuring both the reduced (GSH) and the oxidized states
(GSSG) using the fluorochrome ortho-phthalaldehyde (OPA), at
320 nm and 420 nm, for excitation and emission wavelengths,
respectively.25 Concentrations were estimated based on GSH
and GSSG standard curves (0–10 µM). The ratio between GSH
and GSSG was calculated as the oxidative-stress index (OSI).
The malondialdehyde (MDA) content, an indicator of lipid per-
oxidation (LPO), was measured at 535 nm (excitation) and
550 nm (emission) wavelengths, by the thiobarbituric (TBA)
acid-based method described elsewhere.26 MDA was estimated
based on a standard curve (0–4 nM) of malondialdehyde bis
(dimethyl acetal).
2.4. Statistical analysis
The body weight gain was calculated according to the follow-
ing formula:
Final body weight  Inicial body weight
Final body weight
Statistical analysis was performed using the SPSS program
(Statistical Package for Social Sciences, Chicago, IL, USA)
version 17. A statistical ANOVA followed by the Bonferroni test




The peak characteristics (retention time, λmax in the UV-Vis,
and mass spectral data) and tentative identification of the phe-
nolic compounds present in laurel leaf aqueous extract are pre-
sented in Table 1. Thirty-two compounds were detected from
which fourteen were flavan-3-ols (i.e., catechins and proantho-
cyanidins), fourteen were flavonols and four were flavones.
These compounds were previously described14 in methanol
and infusion extracts obtained from laurel leaves, where
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(−)-epicatechin was the most abundant compound, as also
visualized in the present study.
The stability of these extracts was studied for 5 consecutive
days and it was visualized that by day 4 the concentration of
phenolic compounds began to decrease (Table 2). Therefore,
the feeding water was maintained up to a maximum of 3 days,
to avoid degradation of these compounds.
3.2. Mice experiments
During the experimental work, the animals showed no signs of
behavioral change nor did we register mortality. Fig. 1 shows
the animals’ body weight variation and weight gain for the
different groups under study. At the beginning of the experi-
mental work, there were no differences in the mean body
weight of the animals distributed by the different groups, but
at the end of the study the HPV+/− animals exposed to the
laurel extract had a significantly lower body mass, compared
with matched controls. Fig. 2 shows the mean values of water
and food consumption at the beginning and at the end of the
experimental work. Water consumption was higher in
K14HPV16+/− animals, compared with matched wild-type con-
trols, regardless of whether they received laurel treatment.
There were no differences between groups concerning food
consumption. Table 3 shows the relative weight of the animal’s
organs, for the different groups under study. Only group IV
showed significant differences concerning the weights of the










[M − H]− a (m/z) MS2 a (m/z) Tentative identificationa
Quantification
(µg mL−1)
1 5.1 278 451 289(100) (Epi)catechin-hexoside1 3.6 ± 0.1
2 5.9 278 451 289(100) (Epi)catechin-hexoside1 22 ± 1
3 6.5 276 305 219(13), 179(24), 125(10) ( + )-Gallocatechin1 18 ± 1
4 7.5 278 1151 865(11), 713(16), 577(7), 575(35), 561(5), 289(44) Procyanidin tetramer1 4.65 ± 0.04
5 8.0 279 289 245(79), 203(58), 137(24) ( + )-Catechin1 19.0 ± 0.7
6 8.6 280 577 451(28), 425(60), 407(83), 289(61), 287(13) Procyanidin dimer1 6.4 ± 0.1
7 9.1 279 577 451(49), 425(82), 407(100), 289(69), 287(15) Procyanidin dimer1 29 ± 1
8 11.0 278 289 245 (83), 205(46), 151(24), 137(26) (−)-Epicatechin2 118 ± 2
9 11.7 276 863 711(53), 573(27), 451(30), 411(43), 289(22), 285(9) Procyanidin trimer
(B- and A-type linkages)1
3.07 ± 0.02
10 12.4 278 863 711(46), 573(27), 451(34), 411(46), 289(20), 285(8) Procyanidin trimer
(B- and A-type linkages)1
49.3 ± 0.2
11 13.7 280 1153 865(9), 713(4), 577(29), 575(14), 561(6), 289(23) Procyanidin tetramer1 4.66 ± 0.06
12 14.1 280 1153 865(13), 713(9), 577(33), 575(30), 561(5), 289(61) Procyanidin tetramer1 9.1 ± 0.2
13 14.7 280 865 739(8), 713(17), 695(9), 577(16), 575(25), 425(8),
407(16), 289(7), 287(15)
Procyanidin trimer1 3.8 ± 0.1
14 16.5 350 447 357(72), 327(74), 297(14) Luteolin 6-C-glucoside3 4.69 ± 0.01
15 18.1 337 431 341(16), 311(100) Apigenin 8-C-glucoside4 1.611 ± 0.004
16 18.9 280 577 451(49), 425(85), 407(97), 289(89), 287(22) Procyanidin dimer1 3.51 ± 0.02
17 19.2 338 577 457(8), 413(49), 341(7), 311(6), 293(34) 2″-O-Rhamnosyl-C-hexosyl-apigenin4 2.80 ± 0.01
18 19.6 355 609 301(100) Quercetin 3-O-rutinoside5 0.91 ± 0.03
19 20.2 336 431 341(76), 311(100) Apigenin 6-C-glucoside4 2.44 ± 0.07
20 20.5 356 463 301(100) Quercetin 3-O-glucoside6 3.9 ± 0.2
21 20.9 355 463 301(100) Quercetin O-hexoside6 5.9 ± 0.2
22 23.1 347 593 285(100) Kaempferol 3-O-rutinoside7 1.73 ± 0.02
23 23.4 344 433 301(100) Quercetin O-pentoside6 2.078 ± 0.002
24 23.6 350 447 285(100) Kaempferol 3-O-glucoside8 0.99 ± 0.03
25 24.2 354 623 315(100) Isorhamnetin O-rutinoside9 3.6 ± 0.1
26 24.7 348 447 301(100) Quercetin O-rhamnoside6 5.61 ± 0.09
27 25.0 356 477 315(100) Isorhamnetin O-hexoside9 1.01 ± 0.03
28 25.6 354 477 315(100) Isorhamnetin O-hexoside9 1.40 ± 0.03
29 26.7 347 417 285(100) Kaempferol O-pentoside8 0.62 ± 0.01
30 28.5 355 447 315(100) Isorhamnetin O-pentoside9 tr
31 29.2 343 431 285(100) Kaempferol O-hexoside8 2.48 ± 0.03
32 29.9 350 461 315(100) Isorhamnetin O-rhamnoside9 tr
Total phenolic compounds 336 ± 5
Calibration curves: 1 – catechin (y = 158.42x + 11.38; R2 = 0.999); 2 – epicatechin (y = 129.11x + 11.663, R2 = 0.9999); 3 – luteolin-6-C-glucoside (y =
508.54x−152.82; R2 = 0.997); 4 – apigenin-6-C-glucoside (y = 223.22x + 60.915, R2 = 1); 5 – quercetin-3-O-rutinoside (y = 281.98x−0.3458; R2 = 1);
6 – quercetin-3-O-glucoside (y = 253.52x−11.615; R2 = 0.999); 7 – kaempferol-3-O-rutinoside (y = 239.16x−10.587; R2 = 1); 8 – kaempferol-3-O-glu-
coside (y = 288.55x−4.05; R2 = 1); 9 – isorahmetin-3-O-rutinoside (y = 327.42x + 313.78; R2 = 0.999). aDias et al. (2014b)11,14.
Table 2 Degradation percentage (%) of the main phenolic compounds












8 (−)-Epicatechin 0 3.5 5.3 16.2 16.6
10 Procyanidin trimer (B- and
A-type linkages)
0 5.3 6.0 15.8 17.3
14 Luteolin 6-C-glucoside 0 3.0 5.1 13.3 13.6
21 Quercetin O-hexoside 0 3.5 5.5 16.6 16.3
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left kidney, the liver, the spleen and the lungs. From Table 4
we can observe the serum parameters for the different groups
under study. Wild-type treated mice show mildly elevated
hepatic transaminases compared with untreated controls,
although this did not reach statistical significance. Group III
showed higher values for urea and creatinine compared with the
other groups, which again did not reach statistical significance.
Although microhematocrit values were higher in group IV, there
were no significant differences between groups (Table 4).
Histological analyses of skin samples from wild-type mice
(HPV16−/−) untreated (group I) and treated (group II) showed
normal skin histology (Table 5). Group III showed epidermal
hyperplasia in 60% of the mice and lesions of epidermal dys-
plasia in 40% of the mice, while group IV showed hyperplasia
(40%) and more frequent dysplastic lesions (60%). Fig. 3
shows the representative histological sections of the skin
samples in (A) normal skin, in (B) epidermal hyperplasia and
in (C) epidermal dysplasia.
Fig. 1 Body weight variation (A) (mean ± standard error) and the weight gain (B). W-weight; *p = 0.000, compared with the other groups.
Fig. 2 Mean daily consumption (gram) of food (A) and water (B) per animal in each group. WF-mean food consumption, WW-mean water
consumption.
Table 3 Relative weight of the organs in each experimental group (mean ± standard error)
Groups Left kidney Right kidney Liver Spleen Lungs Heart
Urinary
bladder
I (WT) 0.0063 ± 0.0003 0.0065 ±
0.0001
0.0538 ± 0.0013 0.0054 ± 0.0002 0.0061 ± 0.0002 0.0065 ±
0.0005
0.0047 ± 0.0004




0.0056 ± 0.0002 0.0069 ± 0.0002 0.0064 ±
0.0003
0.0061 ± 0.0011




















aGroup IV: p = 0.000 statistically different from all other groups. bGroup IV: p = 0.000 statistically different from all other groups. cGroup IV: p =
0.002 statistically different from groups I and II. dGroup IV: p = 0.000 statistically different from groups I and II.
Food & Function Paper




















































Concerning liver samples, the mice of group I showed no
hepatic lesions, while half of group II animals showed mild to
moderate hepatitis (Table 5 and Fig. 4). Transgenic animals
showed hepatic lesions typical of their strain, regardless of the
treatment. Concerning the spleen samples, groups I and II pre-
sented 100% normal spleen, while transgenic mice show
typical splenic changes (white pulp hyperplasia), regardless of
the treatment (Table 5). Concerning hepatic oxidative
stress analyses, no significant differences were observed
between groups for any of the markers included in this study
(Table 6).
4. Discussion
The K14HPV16 animal model was developed from FBV/n mice,
in order to study the pathophysiology of HPV-induced lesions.
HPV is an icosahedral symmetry virus with 55 nm diameter.
The HPV viral genome consists of circular double-stranded
DNA,26 and encodes multiple genes, including E6 and E7
which are believed to be essential for HPV-mediated cell trans-
formation.27 HPV belongs to the family Papillomaviridae and
to the genus alpha-papillomavirus28 and is classified into five
genera: alpha, beta, gamma, mu and nu.29 The alpha-papillo-
Table 4 Microhematocrit (Ht) and serum parameters evaluated (mean ± standard error)
Groups Ht (%) Creatininea Ureaa ALTb GGTb ASTb
I (WT) 37.95 0.6675 ± 0.2690 79.9750 ± 12.7943 35.0571 ± 5.9100 0.2286 ± 0.2285 43.7111 ± 16.6996
II (WT + laurel) 39.32 0.4400 ± 0.2314 71.0286 ± 12.6486 37.8800 ± 11.9807 2.1600 ± 2.1600 76.0571 ± 23.3012
III (HPV) 43.22 0.7467 ± 0.3690 103.9000 ± 11.9384 87.6333 ± 24.9806 0.0000 ± 0.0000 93.6000 ± 25.5525
IV (HPV + laurel) 45.05 0.3686 ± 0.2054 78.9143 ± 9.1511 41.4333 ± 12.9350 0.0667 ± 0.0666 107.8857 ± 25.974
aMg dl−1. bU L−1. ALT-Alanine aminotransferase; GGT-gamma glutamyl transferase; AST-aspartate aminotransferase.
Table 5 Histological classification of skin, liver and spleen lesions in transgenic and wild-type mice
Groups n Normal skin Hyperplasia Dysplasia
Skin lesions
I (WT) 10 10/10 (100%) 0/10 (0%) 0/10 (0%)
II (WT + laurel) 10 10/10 (100%) 0/10 (0%) 0/10 (0%)
III (HPV) 10 0/10 (0%) 6/10 (60%) 4/10 (40%)
IV (HPV + laurel) 10 0/10 (0%) 4/10 (40%) 6/10 (60%)
Groups n Normal liver Hepatitis grade I Hepatitis grade II Hepatitis grade III
Liver lesions
I (WT) 10 10/10 (100%) 0/10 (0%) 0/10 (0%) 0/10 (0%)
II (WT + laurel) 10 5/10 (50%) 4/10 (40%) 1/10 (10%) 0/10 (0%)
III (HPV) 10 0/10 (0%) 6/10 (60%) 4/10 (40%) 0/10 (0%)
IV (HPV + laurel) 10 2/10 (20%) 4/10 (40%) 4/10 (40%) 0/10 (0%)
Groups n Normal spleen White pulp hyperplasia Granulomatous splenitis
Spleen lesions
I (WT) 10 10/10 (100%) 0/10 (0%) 0/10 (0%)
II (WT + laurel) 10 10/10 (100%) 0/10 (0%) 0/10 (0%)
III (HPV) 10 9/10 (90%) 1/10 (10%) 0/10 (0%)
IV (HPV + laurel) 10 8/10 (80%) 2/10 (20%) 0/10 (0%)
Fig. 3 Histopathological changes induced by HPV16 oncogenes in FVB/n mice, hematoxylin and eosin stain: (a) normal skin histology, 200×. The
inset shows the normal epidermis with 1 or 2 cell layers (400×). (b) Epidermal hyperplasia, 100×. The inset shows the thickened epidermis with up to
7 cell layers (400×). (c) Epidermal dysplasia, 200×. Note marked parakeratotic hyperkeratosis (Q). The inset shows dysplastic epidermis with supraba-
sal mitotic activity (arrow) (400×).
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mavirus genus is divided into low-risk (e.g. types 6 and 11) and
high-risk HPV types (e.g. types 16 and 18). While low-risk HPV
types are associated with benign lesions such as warts, high-
risk HPV may lead to the development of malignant lesions.30
HPV 16 and 18 are the most common high-risk types associ-
ated with malignant lesions,31 such as carcinomas of the ano-
genital area.32 In this murine model, the human promoter of
the cytokeratin 14 targets the expression of the HPV16 early
genes (including E6 and E7) to the basal layer of the squamous
epithelia,33 recapitulating HPV16-induced carcinogenesis in
the reproductive system and the epidermis.8 This model can
be used to study the development of viral lesions as well as to
evaluate new therapies.
Since ancient times, vegetable extracts have been used for
medicinal purposes, providing the treatment of various dis-
eases and often resulting in the production of drugs.
Medicinal plants have contributed strongly for the develop-
ment of new therapeutic strategies through their secondary
metabolites (e.g. alkaloids, sterols, terpenes, flavonoids, and
saponins)34 which interact with cellular targets.35
Many plant extracts have anti-inflammatory, antimicrobial
and antitumor properties.36 The antitumor activity of the
extract of Laurus nobilis L., popularly known as laurel, has
been studied in vitro before.5,6 This study was designed to
evaluate the efficacy of laurel extract against the cutaneous
lesions of K14HPV16 transgenic mice, and also to assess its
potential in vivo toxicity. This mouse strain shows some par-
ticular frailties, such as chronic hepatic and liver inflam-
mation, which could not be improved by laurel extracts.
During the experimental work, no mortality was recorded
in any group, and there were also no changes in behavior or
other clinical symptoms. These results are interesting, as some
of the signs of toxicity commonly associated with natural com-
pounds are mortality and behavioral changes.37,39 So, laurel
extract administration at this dose did not cause toxicity. The
body mass of HPV+/− animals treated with laurel extract was
significantly lower than the remaining groups. However, these
animals did not show statistically significant differences in
their body mass compared to untreated HPV−/− animals. The
highest water intake was observed in transgenic animals, a
result that has already been described by our team in other
experimental studies in which these animals were used.8
Concerning the relative masses of organs, the HPV+/− group
treated with laurel extract showed statistically significant differ-
ences concerning the left kidney, liver, spleen and lungs com-
pared to group II. Again, no changes were observed in HPV−/−
animals treated with laurel extract. Hepatomegaly is a typical
finding for this strain,8 reflecting chronic hepatic inflam-
mation. In this context, the significance of minor to mild
Fig. 4 Hepatic and splenic changes in HPV16-transgenic mice, hema-
toxylin and eosin: (a) normal liver histology, 100×. (b) Grade I hepatitis,
100×. Note microabscess (arrow) but portal spaces (P) remain free of
inflammatory infiltrates. (c) Grade II hepatitis, 100×. Note marked peri-
portal inflammatory infiltrates (arrows). (d) Grade III hepatitis, 100×.
Note marked periportal inflammatory infiltrate (I) that forms bridges
between adjacent portal areas. (e) Normal splenic histology, showing
red (R) and white (W) pulp, 200×. (f ) Splenic white pulp hyperplasia with
marked predominance of the white pulp component 200×.
Table 6 Oxidative stress parameters evaluated in the liver of the

















































GST f 18.21 ±
5.77













3.04 ± 1.21 2.93 ±
1.19
3.42 ± 1.75
OSIi 8.54 ± 4.6 10.57 ± 7.67 8.57 ±
5.13
5.59 ± 4.65








a nmol DCF per mg protein. bU SOD per mg protein. cU CAT per mg
protein. d nmol NADPH reduced per min mg protein. e nmol NADPH
reduced per min mg protein. f nmol CDNB conjugated per min mg
protein. g µmol GSH per mg protein. h µmol GSSG per mg protein.
iGSH/GSSG. j µmol MDA per mg protein.
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hepatitis, observed in 50% of laurel-treated wild-type mice,
remains unclear. Laurel-treated animals didn’t show signifi-
cant changes in the serum levels of hepatic transaminases,
compared with matched untreated controls, nor did they show
increased hepatic oxidative stress. The weight loss and
increased hepatic weight observed in laurel-treated HPV+/−
mice may reflect a negative impact of laurel in these already
fragile animals. This would be in agreement with previous
in vitro results,11 showing that laurel extracts exert some cyto-
toxicity against hepatocytes. Similarly, the histological changes
observed in wild-type animals may indicate a hepatotoxic
effect. However, this was not accompanied by any of the bio-
chemical markers employed and evaluated oxidative stress
parameters. Hepatic toxicological aspects deserve to be con-
firmed in future in vivo studies, using a dose–response
approach.
K14HPV16 mice develop epidermal hyperplasia that pro-
gresses to dysplasia and carcinoma in situ (CIS) lesions, ulti-
mately evolving into invasive cancer.16 Progression from the
hyperplastic to the dysplastic stage typically occurs between 20
and 30 of age and is accompanied by increased cell prolifer-
ation and multiple immunological and pro-inflammatory
changes.12,13,16,17,38 The percentage of lesions identified in
both transgenic groups (HPV+/− treated and untreated) was
similar, suggesting that the laurel extract had no influence on
the progression of HPV16-induced lesions, in this in vivo
model. These results are in contrast to the in vitro assay pre-
viously conducted on a cervical cancer cell line (HeLa) by Dias
et al.11 This cancer cell line is related to HPV18,40 while the
present mouse model is transgenic for HPV16, which may
perhaps explain this difference, at least in part. In order to
confirm the potential activity of this laurel extract against
lesions caused by HPV18, in vivo studies using an HPV18-trans-
genic mouse strain are recommended. Additional studies
using HPV16-transgenic mice should employ a range of higher
laurel extract doses, and other routes of administration, in
order to confirm whether these are active against HPV-induced
lesions.
5. Conclusion
Overall, the laurel extract was well tolerated by the animals.
However, no efficacy against HPV16-induced lesions was
observed. Further studies are necessary to understand if
different doses of this extract would cause some effects.
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